VITRAKVI
BAYER INC
Quick answers
Is there a shortage of VITRAKVI in Canada?
No. There is no current shortage of VITRAKVI 25MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02490315
Strength
25MG
Dosage Form
Capsule
Route
Oral
Active Ingredient
LAROTRECTINIB (LAROTRECTINIB SULFATE)
See all LAROTRECTINIB (LAROTRECTINIB SULFATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BAYER INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
60MG · DIN 02155990
20MG · DIN 02237618
30MG · DIN 02155907
0.5MG · DIN 02412764
2MG · DIN 02412802
2.5MG · DIN 02412810
1MG · DIN 02412772
1.5MG · DIN 02412799
5MG · DIN 02243919
0.5MG · DIN 02247193
DIN 02309300
220MG · DIN 02436337